Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 377,040 |
|
|||||
| News | - | ||||||
| Day High | 0.7237 | Low High |
|||||
| Day Low | 0.68 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Eyenovia Inc | EYEN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.022 | 3.19% | 0.712 | 23:00:11 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.6919 | 0.68 | 0.7237 | 0.7113 | 0.69 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,955 | 377,040 | US$ 0.7050233 | US$ 265,822 | - | 0.501 - 3.171 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:44:41 | 62 | US$ 0.712 | USD |
Eyenovia Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 31.77M | 44.12M | - | 4k | -27.26M | -0.62 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Eyenovia News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/16/2024 | 16:04 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 5/16/2024 | 15:49 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/15/2024 | 15:19 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 5/06/2024 | 15:01 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders |
| 3/18/2024 | 06:12 | IH Market News | Anticipation Builds on Wall Street for Federal Reserve’s.. |
| 3/11/2024 | 07:11 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/14/2024 | 15:13 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/14/2024 | 15:10 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/31/2024 | 07:13 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
| 1/25/2024 | 06:59 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/16/2024 | 07:24 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/05/2023 | 15:54 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EYEN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.8221 | 0.8699 | 0.68 | 0.7360727 | 633,208 | -0.1101 | -13.39% |
| 1 Month | 0.7343 | 1.14 | 0.5964 | 0.8544804 | 1,144,529 | -0.0223 | -3.04% |
| 3 Months | 2.15 | 2.57 | 0.501 | 1.03 | 1,422,357 | -1.44 | -66.88% |
| 6 Months | 1.36 | 2.57 | 0.501 | 1.27 | 952,488 | -0.648 | -47.65% |
| 1 Year | 3.05 | 3.171 | 0.501 | 1.46 | 632,680 | -2.34 | -76.66% |
| 3 Years | 4.84 | 6.63 | 0.501 | 2.34 | 375,753 | -4.13 | -85.29% |
| 5 Years | 5.10 | 7.72 | 0.501 | 3.03 | 325,106 | -4.39 | -86.04% |
Eyenovia Description
| Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations. |
